Marc Russo Biography and Net Worth

Marc Russo is executive vice president, health plans for Molina Healthcare, Inc. As EVP, health plans, Marc has full P&L responsibility for Molina’s nationwide health plans. Marc has more than two decades of experience in managed care. Prior to joining Molina, he served as president, Medicare for Anthem, Inc. where he grew Anthem’s Medicare business from under $15 billion in annual revenue to over $20 billion in annual revenue under his leadership. Before that, he held leadership roles at WellCare, Blue Shield of California, UnitedHealth Group and Oxford Health Plans.

Marc earned his bachelor’s degree from the University of Connecticut and his master’s degree in business administration from the University of Maryland’s Robert H. Smith School of Business.

What is Marc Russo's net worth?: The estimated net worth of Marc Russo is at least $12.69 million as of August 7th, 2023. Mr. Russo owns 37,093 shares of Molina Healthcare stock worth more than $12,694,337 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Russo may own. Learn More about Marc Russo's net worth.
How do I contact Marc Russo?: The corporate mailing address for Mr. Russo and other Molina Healthcare executives is 200 OCEANGATE SUITE 100, LONG BEACH CA, 90802. Molina Healthcare can also be reached via phone at (562) 435-3666 and via email at [email protected]. Learn More on Marc Russo's contact information.
Has Marc Russo been buying or selling shares of Molina Healthcare?: Marc Russo has not been actively trading shares of Molina Healthcare within the last three months. Most recently, Marc Russo sold 2,523 shares of the business's stock in a transaction on Monday, August 7th. The shares were sold at an average price of $312.72, for a transaction totalling $788,992.56. Following the completion of the sale, the executive vice president now directly owns 37,093 shares of the company's stock, valued at $11,599,722.96. Learn More on Marc Russo's trading history.
Who are Molina Healthcare's active insiders?: Molina Healthcare's insider roster includes Jeff Barlow (Insider), Barbara Brasier (Director), Garrey Carruthers (Director), Daniel Cooperman (Director), Maurice Hebert (CAO), Mark Keim (CFO), Steven Orlando (Director), Ronna Romney (Director), Marc Russo (EVP), Richard Schapiro (Director), Thomas Tran (EVP), Dale Wolf (Director), James Woys (EVP), and Joseph Zubretsky (CEO). Learn More on Molina Healthcare's active insiders.
Are insiders buying or selling shares of Molina Healthcare?: In the last year, insiders at the sold shares 10 times. They sold a total of 36,118 shares worth more than $12,436,421.41. The most recent insider tranaction occured on February, 20th when Director Richard M Schapiro sold 1,000 shares worth more than $401,050.00. Insiders at Molina Healthcare own 1.1% of the company. Learn More about insider trades at Molina Healthcare.
Information on this page was last updated on 2/20/2024.

Marc Russo Insider Trading History at Molina Healthcare

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/7/2023	Sell	2,523	$312.72	$788,992.56	37,093
12/12/2022	Sell	1,500	$351.17	$526,755.00	15,513

Marc Russo Buying and Selling Activity at Molina Healthcare

Molina Healthcare Company Overview

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Today's Range

Now: $342.23

$336.87

$349.99

50 Day Range

MA: $390.34

$342.23

$419.59

2 Week Range

Now: $342.23

$266.35

$423.92

Volume

593,393 shs

Average Volume

431,658 shs

Market Capitalization

$20.05 billion

P/E Ratio

18.57

Dividend Yield

N/A

Beta

0.47

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>